The Lymphoma Academic Research Organisation

This study is testing whether a new two-drug combination (Mosunetuzumab and Lenalidomide) works better than current standard treatments for people with a specific type of lymphoma that has come back or stopped responding to prior therapy. It will involve about 260 adults whose ca…

This study is testing new drugs and drug combinations for adults whose peripheral T-cell lymphoma has returned or not responded to previous treatments. It's a flexible 'platform trial' that can test multiple different treatments in small groups of patients. The main goals are to …

This study is testing two different combinations of three drugs (glofitamab, venetoclax, and zanubrutinib) for people with a high-risk form of mantle cell lymphoma, a type of blood cancer. It is for adults who are either newly diagnosed with very high-risk features or whose cance…

This study is testing a new three-drug combination for people with an aggressive type of brain lymphoma that has come back or stopped responding to prior treatment. The goal is to see if adding a new immune-boosting drug called epcoritamab to two existing drugs can better control…

This study looks back at the medical records of about 250 patients in France who have already received a lymphoma drug called Glofitamab. The goal is to understand how well the treatment worked and how safe it was in everyday medical practice, especially for patients whose cancer…

This study is creating a large French registry to collect information on patients with blood cancers who are eligible for CAR-T cell therapy. It will track 5,000 patients to understand how well the treatment works, how long patients survive, and potential delays in receiving care…

This study is creating a national registry to collect information on a rare type of lymphoma linked to breast implants. It will enroll 150 adult women in France and Belgium who have been diagnosed with this condition. The goal is to gather data to help doctors better understand a…